| Renal protective effects of pitavastatin on spontaneously hypercholesterolaemic Imai Rats. | |
| | |
MedLine Citation:
|
PMID: 17550926 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Independent of their lipid-lowering effects, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors have renal protective effects on various models of progressive renal diseases, therefore, additional therapeutic advantages have been considered. In the present study, using spontaneously hypercholesterolaemic Imai rats, we examined the protective effects of pitavastatin on renal injuries and the oxidative modification of the low-density lipoprotein (LDL) and high-density lipoprotein (HDL), since oxidized lipoproteins are speculated to be involved in the mechanism of this rat strain's renal injuries. METHODS: Male Imai rats were treated with pitavastatin (n = 11) at a dose of 100 mg/kg diet or received no specific therapy as controls (n = 11) from 10 to 22 weeks of age. Body weight, urinary protein excretion and serum constituents were evaluated every 4 weeks. At the end of the study, the effects of pitavastatin on the susceptibility of serum LDL and HDL to oxidation, and renal histology were examined. RESULTS: Pitavastatin treatment did not affect hyperlipidaemia, but significantly reduced proteinuria and preserved creatinine clearance deterioration. At the end of the study, lag times for LDL and HDL oxidation were prolonged by the treatment of pitavastatin to 126 and 153%, respectively, compared with the controlled group. The glomerulosclerosis index (SI) for untreated controlled rats was significantly higher than that for the pitavastatin-treated group. An immunohistochemistry study showed significantly lower numbers of ED-1 positive macrophages in the glomeruli and interstitium in pitavastatin-treated rats compared with those controlled. CONCLUSION: Pitavastatin treatment prevented renal injuries in Imai rats independent of lipid-lowering effects. Prevention of oxidative modification of LDL and HDL may play an important role on the beneficial effects of pitavastatin treatment. |
| | |
Authors:
|
Xiang-Ming Liang; Haruhisa Otani; Qin Zhou; Yoshinori Tone; Ryoichi Fujii; Masatoshi Mune; Susumu Yukawa; Tadao Akizawa |
Related Documents
:
|
1343296 - Manidipine attenuates a progressive renal injury in remnant kidneys of rats. 1943126 - Method for studying the in vivo accumulation of inorganic mercury in segments of the ne... 21970406 - Assessment of proteolytic degradation of the basement membrane: a fragment of type iv ... 2269026 - The renal functions following a profound hypothermia in rats. 2988916 - Corticotropin-releasing factor stimulation of adrenocorticotropin and beta-endorphin re... 10741586 - Generation of peroxynitrite in localised, moderate temperature burns. |
Publication Detail:
|
Type: Journal Article Date: 2007-06-05 |
Journal Detail:
|
Title: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Volume: 22 ISSN: 0931-0509 ISO Abbreviation: Nephrol. Dial. Transplant. Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-07-26 Completed Date: 2007-11-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8706402 Medline TA: Nephrol Dial Transplant Country: England |
Other Details:
|
Languages: eng Pagination: 2156-64 Citation Subset: IM |
Affiliation:
|
Department of Nephrology, Qilu Hospital of Shandong University, Shandong Province, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Pressure Blood Urea Nitrogen Deoxyguanosine / analogs & derivatives, urine Enzyme Inhibitors / pharmacology Hypercholesterolemia / pathology* Hyperlipidemias / metabolism Kidney / drug effects, pathology* Lipids / chemistry Lipoproteins, HDL / metabolism Lipoproteins, LDL / metabolism Macrophages / metabolism Oxygen / metabolism Quinolines / pharmacology* Rats |
| Chemical | |
Reg. No./Substance:
|
0/8-hydroxy-2'-deoxyguanosine; 0/Enzyme Inhibitors; 0/Lipids; 0/Lipoproteins, HDL; 0/Lipoproteins, LDL; 0/Quinolines; 147526-32-7/NK 104; 7782-44-7/Oxygen; 961-07-9/Deoxyguanosine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.
Next Document: Review on uraemic solutes II--variability in reported concentrations: causes and consequences.